UK markets closed

AgeX Therapeutics, Inc. (AGE)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.7779-0.1021 (-11.60%)
At close: 04:00PM EST
0.7800 +0.00 (+0.27%)
After hours: 05:32PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
1,782
1,868
1,728
1,396
Cost of revenue
155
158
244
364
Gross profit
1,627
1,710
1,484
1,032
Operating expenses
Research development
3,249
4,978
5,904
6,630
Selling general and administrative
7,448
7,403
8,139
5,647
Total operating expenses
10,697
12,381
14,043
12,277
Operating income or loss
-9,070
-10,671
-12,559
-11,245
Total other income/expenses net
589
44
294
3,398
Income before tax
-9,560
-11,126
-12,236
-7,731
Income tax expense
-
-150
148
-
Income from continuing operations
-9,410
-10,976
-12,384
-7,731
Net income
-8,963
-10,865
-12,154
-7,502
Net income available to common shareholders
-8,963
-10,865
-12,154
-7,502
Basic EPS
-
-0.29
-0.33
-0.21
Diluted EPS
-
-0.29
-0.33
-0.21
Basic average shares
-
37,669
37,271
34,914
Diluted average shares
-
37,669
37,271
34,914
EBITDA
-
-8,989
-11,608
-10,710